Presentation ESC 2022

Efficacy and Safety of the Oral Factor XIa Inhibitor, Asundexian, Added to Dual Antiplatelet Therapy After an Acute Myocardial Infarction

Presenter: John H. Alexander

REGISTER for free or LOG IN to view this content

Efficacy and Safety of the Oral Factor XIa Inhibitor, Asundexian, Added to Dual Antiplatelet Therapy After an Acute Myocardial Infarction
Coronary
CAD Pharma
ACS/AMI
Presentation
ESC 2022

Up Next

More slides +

We Recommend